Project: A cost effective and time saving blood test to detect six human bloodborne infectious diseases

Acronym SAFEBLOOD (Reference Number: 113590)
Duration 01/01/2020 - 03/01/2023
Project Topic The consortium will develop a new in vitro diagnostic (IVD) test to screen donated blood for bloodborne infectious pathogens, saving blood banks time and costs required for analysis of mandatory pathogens. The IVD test is a multiplex immunoassay that simultaneously screens for six bloodborne infectious diseases per blood sample. In this project, a mix of diagnostic protein markers will be developed and validated to lockdown an IVD test ready for commercial scale-up and CE-IVD certification.
Network Eurostars 2
Call Eurostars Cut–off 11

Project partner

Number Name Role Country
1 WAMA Diagnostics Coordinator Switzerland
2 InfYnity Biomarkers Partner France
3 University Hospital of Montpellier Partner France